Software and AI medical device compliance represents one of the most complex and rapidly evolving areas of regulatory science. It requires integration of traditional quality management principles with advanced computational controls, data governance.
The compliance priorities for 2027 reflect a clear shift toward integrated, data-driven, and scientifically structured regulatory frameworks.
The TGA compliance principles are grounded in scientific rigor, risk-based thinking, and lifecycle control of therapeutic goods.
The ISO 13485 transition project for the IVD manufacturer demonstrates a comprehensive approach to quality system enhancement within a regulated medical device environment.